Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;65(5):1451-1461.
doi: 10.1111/epi.17943. Epub 2024 Mar 16.

Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis

Robert J Carton  1   2 , Michael G Doyle  1   2   3   4 , Hugh Kearney  1   3 , Charles A Steward  5 , Nicholas J Lench  5 , Anthony Rogers  5 , Erin L Heinzen  6 , Seamus McDonald  2 , Joanna Fay  7 , Austin Lacey  1 , Alan Beausang  8 , Jane Cryan  8 , Francesca Brett  8 , Hany El-Naggar  1   3 , Peter Widdess-Walsh  1   3 , Daniel Costello  1   9 , Ronan Kilbride  1   3 , Colin P Doherty  1   10 , Kieron J Sweeney  1   3 , Donncha F O'Brien  1   3 , David C Henshall  1 , Norman Delanty  1   2   3 , Gianpiero L Cavalleri  1   2 , Katherine A Benson  1   2
Affiliations

Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis

Robert J Carton et al. Epilepsia. 2024 May.

Abstract

Objective: The contribution of somatic variants to epilepsy has recently been demonstrated, particularly in the etiology of malformations of cortical development. The aim of this study was to determine the diagnostic yield of somatic variants in genes that have been previously associated with a somatic or germline epilepsy model, ascertained from resected brain tissue from patients with multidrug-resistant focal epilepsy.

Methods: Forty-two patients were recruited across three categories: (1) malformations of cortical development, (2) mesial temporal lobe epilepsy with hippocampal sclerosis, and (3) nonlesional focal epilepsy. Participants were subdivided based on histopathology of the resected brain. Paired blood- and brain-derived DNA samples were sequenced using high-coverage targeted next generation sequencing to high depth (585× and 1360×, respectively). Variants were identified using Genome Analysis ToolKit (GATK4) MuTect-2 and confirmed using high-coverage Amplicon-EZ sequencing.

Results: Sequence data on 41 patients passed quality control. Four somatic variants were validated following amplicon sequencing: within CBL, ALG13, MTOR, and FLNA. The diagnostic yield across 41 patients was 10%, 9% in mesial temporal lobe epilepsy with hippocampal sclerosis and 20% in malformations of cortical development.

Significance: This study provides novel insights into the etiology of mesial temporal lobe epilepsy with hippocampal sclerosis, highlighting a potential pathogenic role of somatic variants in CBL and ALG13. We also report candidate diagnostic somatic variants in FLNA in focal cortical dysplasia, while providing further insight into the importance of MTOR and related genes in focal cortical dysplasia. This work demonstrates the potential molecular diagnostic value of variants in both germline and somatic epilepsy genes.

Keywords: drug‐resistant epilepsy; mesial temporal lobe epilepsy with hippocampal sclerosis; somatic variants.

PubMed Disclaimer

Similar articles

See all similar articles

References

REFERENCES

    1. Myers CT, Mefford HC. Advancing epilepsy genetics in the genomic era. Genome Med. 2015;7(1):91.
    1. Nolan D, Fink J. Genetics of epilepsy. Handb Clin Neurol. 2018;148:467–491.
    1. Kearney H, Byrne S, Cavalleri GL, Delanty N. Tackling epilepsy with high‐definition precision medicine: a review. JAMA Neurol. 2019;76(9):1109–1116.
    1. Poduri A, Evrony GD, Cai X, Walsh CA. Somatic mutation, genomic variation, and neurological disease. Science. 2013;341(6141):1237758.
    1. Mirzaa GM, Campbell CD, Solovieff N, Goold CP, Jansen LA, Menon S, et al. Association of MTOR mutations with developmental brain disorders, including Megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol. 2016;73(7):836–845.

Publication types

MeSH terms

LinkOut - more resources

-